Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts

Biochemical and Biophysical Research Communications

Volumn 346, Issue 1, 2006, Pages 367-376

  Wang, Zhirong ^a   Chen, Yan ^a   Labinskyy, Nazar ^a   Hsieh, Tze chen ^a   Ungvari, Zoltan ^a   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

HASMC proliferation; Resveratrol; Resveratrol affinity chromatography; RTP (resveratrol targeting protein); Standardized grape extracts; Subcellular fractionation

Indexed keywords

ALCOHOL; HEAT SHOCK PROTEIN 27; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RESVERATROL;

AFFINITY CHROMATOGRAPHY; AORTA MEDIA; ARTICLE; CAROTID ARTERY; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOSE RESPONSE; FRACTIONATION; GENE CONTROL; GENE EXPRESSION; GRAPE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE;

AORTA; APOPTOSIS INDUCING FACTOR; CARDIOTONIC AGENTS; CELL PROLIFERATION; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; ELECTRON TRANSPORT COMPLEX IV; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HUMANS; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NAD(P)H DEHYDROGENASE (QUINONE); NITRIC OXIDE SYNTHASE TYPE III; PLANT EXTRACTS; STILBENES; TUMOR SUPPRESSOR PROTEIN P53; VITIS; WINE;

VITIS SP.;

EID: 33745000727     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.156     Document Type: Article

References (73)

1. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., and Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
2. Soleas G.J., Diamandis E.P., and Goldberg D.M. Resveratrol: a molecule whose time has come? And gone?. Clin. Biochem. 30 (1997) 91-113
3. Soleas G.J., Diamandis E.P., and Goldberg D.M. The world of resveratrol. Adv. Exp. Med. Biol. 492 (2001) 159-182
4. St. Leger A.S., Cochrane A.L., and Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1 (1979) 1017-1020
5. Burns J., Crozier A., and Lean M.E. Alcohol consumption and mortality: is wine different from other alcoholic beverages?. Nutr. Metab. Cardiovasc. Dis. 11 (2001) 249-258
6. Lin J.K., and Tsai S.H. Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc. Natl. Sci. Counc. Repub. China B. 23 (1999) 99-106
7. da Luz P.L., and Coimbra S.R. Wine, alcohol and atherosclerosis: clinical evidences and mechanisms. Braz. J. Med. Biol. Res. 37 (2004) 1275-1295
8. Burns J., Gardner P.T., O'Neil J., Crawford S., Morecroft I., McPhail D.B., Lister C., Matthews D., MacLean M.R., Lean M.E., Duthie G.G., and Crozier A. Relationship among antioxidant activity, vasodilation capacity, and phenolic content of red wines. J. Agric. Food Chem. 48 (2000) 220-230
9. German J.B., and Walzem R.L. The health benefits of wine. Annu. Rev. Nutr. 20 (2000) 561-593
10. Renaud S., and de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339 (1992) 1523-1526
11. Hung L.M., Chen J.K., Huang S.S., Lee R.S., and Su M.J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47 (2000) 549-555
12. Zou J., Huang Y., Chen Q., Wei E., Cao K., and Wu J.M. Effects of resveratrol on oxidative modification of human low density lipoprotein. Chin. Med. J. (Engl.) 113 (2000) 99-102
13. Zou J.G., Huang Y.Z., Chen Q., Wei E.H., Hsieh T.C., and Wu J.M. Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein. Biochem. Mol. Biol. Int. 47 (1999) 1089-1096
14. Kaga S., Zhan L., Matsumoto M., and Maulik N. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J. Mol. Cell. Cardiol. 39 (2005) 813-822
15. Sato M., Maulik G., Bagchi D., and Das D.K. Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin. Free Radic. Res. 32 (2000) 135-144
16. 3-induced model of posttraumatic seizures in rats. Methods Find Exp. Clin. Pharmacol. 23 (2001) 241-244
17. Stivala L.A., Savio M., Carafoli F., Perucca P., Bianchi L., Maga G., Forti L., Pagnoni U.M., Albini A., Prosperi E., and Vannini V. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem. 276 (2001) 22586-22594
18. Cai Y.J., Fang J.G., Ma L.P., Yang L., and Liu Z.L. Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues. Biochim. Biophys. Acta 1637 (2003) 31-38
19. Lu M., Cai Y.J., Fang J.G., Zhou Y.L., Liu Z.L., and Wu L.M. Efficiency and structure-activity relationship of the antioxidant action of resveratrol and its analogs. Pharmazie 57 (2002) 474-478
20. Wu J.M., Wang Z.R., Hsieh T.C., Bruder J.L., Zou J.G., and Huang Y.Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review). Int. J. Mol. Med. 8 (2001) 3-17
21. Das D.K., Sato M., Ray P.S., Maulik G., Engelman R.M., Bertelli A.A., and Bertelli A. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp. Clin. Res. 25 (1999) 115-120
22. Kirk R.I., Deitch J.A., Wu J.M., and Lerea K.M. Resveratrol decreases early signaling events in washed platelets but has little effect on platalet in whole food. Blood Cells Mol. Dis. 26 (2000) 144-150
23. Wang Z., Zou J., Huang Y., Cao K., Xu Y., and Wu J.M. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin. Med. J. (Engl.) 115 (2002) 378-380
24. Hao H.D., and He L.R. Mechanisms of cardiovascular protection by resveratrol. J. Med. Food 7 (2004) 290-298
25. Fitzpatrick D.F., Hirschfield S.L., and Coffey R.G. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am. J. Physiol. 265 (1993) H774-H778
26. Naderali E.K., Smith S.L., Doyle P.J., and Williams G. The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats. Clin. Sci. (Lond) 100 (2001) 55-60
27. Naderali E.K., Doyle P.J., and Williams G. Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs. Clin. Sci. (Lond.) 98 (2000) 537-543
28. Hsieh T.C., Juan G., Darzynkiewicz Z., and Wu J.M. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59 (1999) 2596-2601
29. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., and Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106 (2002) 1652-1658
30. MacCarrone M., Lorenzon T., Guerrieri P., and Agro A.F. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem. 265 (1999) 27-34
31. Wang Z., Hsieh T.C., Zhang Z., Ma Y., and Wu J.M. Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography. Biochem. Biophys. Res. Commun. 323 (2004) 743-749
32. Kinghorn A.D., Su B.N., Jang D.S., Chang L.C., Lee D., Gu J.Q., Carcache-Blanco E.J., Pawlus A.D., Lee S.K., Park E.J., Cuendet M., Gills J.J., Bhat K., Park H.S., Mata-Greenwood E., Song L.L., Jang M., and Pezzuto J.M. Natural inhibitors of carcinogenesis. Planta Med. 70 (2004) 691-705
33. Buryanovskyy L., Fu Y., Boyd M., Ma Y., Hsieh T.C., Wu J.M., and Zhang Z. Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 43 (2004) 11417-11426
34. Hsieh T.C., Wang Z., Hamby C.V., and Wu J.M. Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53. Biochem. Biophys. Res. Commun. 334 (2005) 223-230
35. Zou J., Huang Y., Chen Q., Wang N., Cao K., Hsieh T.C., and Wu J.M. Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells. Int. J. Oncol. 15 (1999) 647-651
36. Haider U.G., Sorescu D., Griendling K.K., Vollmar A.M., and Dirsch V.M. Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Mol. Pharmacol. 63 (2003) 925-932
37. Haider U.G., Sorescu D., Griendling K.K., Vollmar A.M., and Dirsch V.M. Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol. Pharmacol. 62 (2002) 772-777
38. Araim O., Ballantyne J., Waterhouse A.L., and Sumpio B.E. Inhibition of vascular smooth muscle cell proliferation with red wine and red wine polyphenols. J. Vasc. Surg. 35 (2002) 1226-1232
39. Zou J., Huang Y., Cao K., Yang G., Yin H., Len J., Hsieh T.C., and Wu J.M. Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit model. Life Sci. 68 (2000) 153-163
40. Zou J.G., Wang Z.R., Huang Y.Z., Cao K.J., and Wu J.M. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int. J. Mol. Med. 11 (2003) 317-320
41. Wang Z., Zou J., Cao K., Hsieh T.C., Huang Y., and Wu J.M. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int. J. Mol. Med. 16 (2005) 533-540
42. Morre D.M., and Morre D.J. Anticancer activity of grape and grape skin extracts alone and combined with green tea infusions. Cancer Lett. (2005)
43. Hsieh T.C., and Wu J.M. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell Res. 249 (1999) 109-115
44. Hsieh T.C., and Wu J.M. Effects of the retinoid 4-HPR on human prostate growth, induction of apoptosis and modulation of androgen receptor (AR) and prostate specific antigen (PSA) expression. The Prostate 33 (1997) 97-104
45. DiPietrantonio A.M., Hsieh T.C., Juan G., Traganos F., Darzynkiewicz Z., and Wu J.M. Fenretinide-induced caspase 3 activity involves increased protein stability in a mechanism distinct from reactive oxygen species elevation. Cancer Res. 60 (2000) 4331-4335
46. Csiszar A., Ahmad M., Smith K.E., Labinskyy N., Gao Q., Kaley G., Edwards J.G., Wolin M.S., and Ungvari Z. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. Am. J. Pathol. 168 (2006) 629-638
47. Yonemitsu Y., Kaneda Y., Tanaka S., Nakashima Y., Komori K., Sugimachi K., and Sueishi K. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ. Res. 82 (1998) 147-156
48. Mnjoyan Z.H., and Fujise K. Profound negative regulatory effects by resveratrol on vascular smooth muscle cells: a role of p53-p21(WAF1/CIP1) pathway. Biochem. Biophys. Res. Commun. 311 (2003) 546-552
49. Bennett M.R., Evan G.I., and Schwartz S.M. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ. Res. 77 (1995) 266-273
50. Rodriguez-Campos A., Ruiz-Enriquez P., Faraudo S., and Badimon L. Mitogen-induced p53 downregulation precedes vascular smooth muscle cell migration from healthy tunica media and proliferation. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 214-219
51. Condorelli G., Aycock J.K., Frati G., and Napoli C. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. FASEB J. 15 (2001) 2162-2170
52. Gao C., Zou Z., Xu L., Moul J., Seth P., and Srivastava S. p53-dependent induction of heat shock protein 27 (HSP27) expression. Int. J. Cancer 88 (2000) 191-194
53. Connolly E.M., Kelly C.J., Chen G., O'Grady T., Kay E., Leahy A., and Bouchier-Hayes D.J. Pharmacological induction of HSP27 attenuates intimal hyperplasia in vivo. Eur. J. Vasc. Endovasc. Surg. 25 (2003) 40-47
54. Park K.J., Gaynor R.B., and Kwak Y.T. Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappa B activation. J. Biol. Chem. 278 (2003) 35272-35278
55. Bellas R.E., Lee J.S., and Sonenshein G.E. Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J. Clin. Invest. 96 (1995) 2521-2527
56. Zuckerbraun B.S., McCloskey C.A., Mahidhara R.S., Kim P.K., Taylor B.S., and Tzeng E. Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation. J. Vasc. Surg. 38 (2003) 812-819
57. Mehrhof F.B., Schmidt-Ullrich R., Dietz R., and Scheidereit C. Regulation of vascular smooth muscle cell proliferation: role of NF-kappaB revisited. Circ. Res. 96 (2005) 958-964
58. Labinskyy N., Csiszar A., Veress G., Stef G., Pacher P., Oroszi G., Wu J., and Ungvari Z. Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen. Curr. Med. Chem. 13 (2006) 989-996
59. Iskander K., Paquet M., Brayton C., and Jaiswal A.K. Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis. Cancer Res. 64 (2004) 5925-5928
60. Asher G., Lotem J., Kama R., Sachs L., and Shaul Y. NQO1 stabilizes p53 through a distinct pathway. Proc. Natl. Acad. Sci. USA 99 (2002) 3099-3104
61. Asher G., Lotem J., Cohen B., Sachs L., and Shaul Y. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc. Natl. Acad. Sci. USA 98 (2001) 1188-1193
62. Floreani M., Napoli E., and Palatini P. Protective action of cardiac DT-diaphorase against menadione toxicity in guinea pig isolated atria. Biochem. Pharmacol. 60 (2000) 601-605
63. Cao Z., and Li Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur. J. Pharmacol. 489 (2004) 39-48
64. Floreani M., Napoli E., Quintieri L., and Palatini P. Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Sci. 72 (2003) 2741-2750
65. Currie R.W. Effects of ischemia and perfusion temperature on the synthesis of stress-induced (heat shock) proteins in isolated and perfused rat hearts. J. Mol. Cell. Cardiol. 19 (1987) 795-808
66. Das D.K., Engelman R.M., and Kimura Y. Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. Cardiovasc. Res. 27 (1993) 578-584
67. Hutter M.M., Sievers R.E., Barbosa V., and Wolfe C.L. Heat-shock protein induction in rat hearts. A direct correlation between the amount of heat-shock protein induced and the degree of myocardial protection. Circulation 89 (1994) 355-360
68. Knowlton A.A., Brecher P., and Apstein C.S. Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. J. Clin. Invest. 87 (1991) 139-147
69. Pieper G.M. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31 (1998) 1047-1060
70. Felaco M., Grilli A., De Lutiis M.A., Patruno A., Libertini N., Taccardi A.A., Di Napoli P., Di Giulio C., Barbacane R., and Conti P. Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts. Ann. Clin. Lab. Sci. 31 (2001) 179-186
71. Trovati M., Massucco P., Mattiello L., Costamagna C., Aldieri E., Cavalot F., Anfossi G., Bosia A., and Ghigo D. Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3′:5′-cyclic monophosphate and adenosine 3′:5′-cyclic monophosphate concentrations. Diabetologia 42 (1999) 831-839
72. Papapetropoulos A., Rudic R.D., and Sessa W.C. Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc. Res. 43 (1999) 509-520
73. Shaul P.W. Regulation of endothelial nitric oxide synthase: location, location, location. Annu. Rev. Physiol. 64 (2002) 749-774